Ebola Virus: a Clear and Present Danger

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2014 Nov 14

PMID 25392362

Citations 13

Authors

Eileen M Burd

Affiliations

Soon will be listed here.

Abstract

An epidemic of Ebola virus disease is occurring in Western Africa on a scale not seen before, particularly in the countries of Guinea, Liberia, and Sierra Leone. The continued spread is facilitated by insufficient medical facilities, poor sanitation, travel, and unsafe burial practices. Several patients diagnosed with Ebola virus disease in Africa have been evacuated to the United States for treatment, and several other patients have been diagnosed in the United States. It is important for laboratories to be aware of available tests, especially those granted emergency use authorization, as hospitals prepare protocols for the diagnosis and management of high-risk patients.

Citing Articles

Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines.

Guo X, Liu D, Huang Y, Deng Y, Wang Y, Mao J Virol J. 2023; 20(1):64.

PMID: 37029389 PMC: 10081822. DOI: 10.1186/s12985-023-02023-0.

Structural risk analysis of a potential Ebola outbreak with respect to infrastructural aspects amid the current COVID-19 pandemic.

Arafkas M, Osseni I, Schubert J, Bania J, Kulas J, Khosrawipour V Med Int (Lond). 2023; 1(3):7.

PMID: 36698867 PMC: 9855279. DOI: 10.3892/mi.2021.7.

Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment.

Chakrabartty I, Khan M, Mahanta S, Chopra H, Dhawan M, Choudhary O Ann Med Surg (Lond). 2022; 79:103985.

PMID: 35721786 PMC: 9188442. DOI: 10.1016/j.amsu.2022.103985.

The Need for Dedicated Microbiology Leadership in the Clinical Microbiology Laboratory.

Samuel L, Hansen G, Kraft C, Pritt B J Clin Microbiol. 2021; 59(8):e0154919.

PMID: 33597258 PMC: 8288296. DOI: 10.1128/JCM.01549-19.

Contact Transmission of Vaccinia to an Infant Diagnosed by Viral Culture and Metagenomic Sequencing.

Martin R, Burke K, Verma D, Xie H, Langer J, Schlaberg R Open Forum Infect Dis. 2020; 7(4):ofaa111.

PMID: 32685604 PMC: 7357282. DOI: 10.1093/ofid/ofaa111.

References

Sobarzo A, Ochayon D, Lutwama J, Balinandi S, Guttman O, Marks R . Persistent immune responses after Ebola virus infection. N Engl J Med. 2013; 369(5):492-3. DOI: 10.1056/NEJMc1300266. View

Gire S, Goba A, Andersen K, Sealfon R, Park D, Kanneh L . Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014; 345(6202):1369-72. PMC: 4431643. DOI: 10.1126/science.1259657. View

Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N . Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014; 371(15):1418-25. DOI: 10.1056/NEJMoa1404505. View

Gibb T, Norwood Jr D, Woollen N, Henchal E . Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain). Clin Diagn Lab Immunol. 2002; 9(1):19-27. PMC: 119875. DOI: 10.1128/cdli.9.1.19-27.2002. View

Saijo M, Niikura M, Ikegami T, Kurane I, Kurata T, Morikawa S . Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol. 2006; 13(4):444-51. PMC: 1459631. DOI: 10.1128/CVI.13.4.444-451.2006. View

Lucht A, Grunow R, Otterbein C, Moller P, Feldmann H, Becker S . Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol. 2003; 193(4):181-7. DOI: 10.1007/s00430-003-0204-z. View

Wong G, Kobinger G, Qiu X . Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol. 2014; 10(6):781-90. DOI: 10.1586/1744666X.2014.908705. View

Kuhn J, Becker S, Ebihara H, Geisbert T, Johnson K, Kawaoka Y . Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol. 2010; 155(12):2083-103. PMC: 3074192. DOI: 10.1007/s00705-010-0814-x. View

Leroy E, Baize S, Lu C, McCormick J, Georges A, Georges-Courbot M . Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol. 2000; 60(4):463-7. View

10.

Bausch D, Towner J, Dowell S, Kaducu F, Lukwiya M, Sanchez A . Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007; 196 Suppl 2:S142-7. DOI: 10.1086/520545. View

11.

El Mekki A, van der Groen G . A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhagic viruses in cell cultures. J Virol Methods. 1981; 3(2):61-9. DOI: 10.1016/0166-0934(81)90002-1. View

12.

Meltzer M, Atkins C, Santibanez S, Knust B, Petersen B, Ervin E . Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Suppl. 2014; 63(3):1-14. View

13.

Panning M, Laue T, Olschlager S, Eickmann M, Becker S, Raith S . Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis. 2007; 196 Suppl 2:S199-204. PMC: 7109892. DOI: 10.1086/520600. View

14.

MacNeil A, Reed Z, Rollin P . Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis. 2011; 5(6):e1175. PMC: 3110169. DOI: 10.1371/journal.pntd.0001175. View

15.

Piercy T, Smither S, Steward J, Eastaugh L, Lever M . The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol. 2010; 109(5):1531-9. DOI: 10.1111/j.1365-2672.2010.04778.x. View

16.

Johnson K, Lange J, WEBB P, Murphy F . Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet. 1977; 1(8011):569-71. DOI: 10.1016/s0140-6736(77)92000-1. View

17.

Drosten C, Kummerer B, Schmitz H, Gunther S . Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res. 2003; 57(1-2):61-87. DOI: 10.1016/s0166-3542(02)00201-2. View

18.

Stroher U, West E, Bugany H, Klenk H, Schnittler H, Feldmann H . Infection and activation of monocytes by Marburg and Ebola viruses. J Virol. 2001; 75(22):11025-33. PMC: 114683. DOI: 10.1128/JVI.75.22.11025-11033.2001. View

19.

Ansari A . Clinical features and pathobiology of Ebolavirus infection. J Autoimmun. 2014; 55:1-9. DOI: 10.1016/j.jaut.2014.09.001. View

20.

FRANZ D, Jahrling P, Friedlander A, McClain D, Hoover D, Bryne W . Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997; 278(5):399-411. DOI: 10.1001/jama.278.5.399. View